Insulin glargine and lixisenatide and Teveten HCT
Determining the interaction of Insulin glargine and lixisenatide and Teveten HCT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: eprosartan / hydrochlorothiazide
Brand name: Teveten HCT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Texacort
- Insulin glargine and lixisenatide-Tezacaftor and Ivacaftor
- Insulin glargine and lixisenatide-Tezacaftor/ivacaftor and ivacaftor
- Insulin glargine and lixisenatide-TGQ 30PSE/3BRM/15DM
- Insulin glargine and lixisenatide-TGQ 7.5PEH/4BRM/15DM
- Insulin glargine and lixisenatide-TGT First Aid Antibiotic
- Teveten HCT-Insulin glargine and lixisenatide Subcutaneous
- Teveten HCT-Insulin glargine, recombinant Subcutaneous
- Teveten HCT-Insulin glulisine
- Teveten HCT-Insulin Glulisine (Cartridges and Pens)
- Teveten HCT-Insulin Glulisine (Vials)
- Teveten HCT-Insulin glulisine Subcutaneous